New Issue: Barclays prices $642,000 autocallable fixed-coupon notes on biotech ETF

Chicago, May 18 – Barclays Bank plc priced $642,000 of 7% autocallable fixed-coupon notes due Nov. 3, 2022 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable monthly.

The notes will be automatically called at par if the fund closes at or above its initial level on any semiannual call date.

If the notes are not called, the payout at maturity will be par unless the fund finishes below 75% of its initial level, in which cases investors will lose 1% for each 1% of the fund below the initial value.

Barclay is the agent.

Issuer:	Barclays Bank plc
Issue:	Autocallable fixed-coupon notes
Underlying fund:	SPDR S&P Biotech ETF
Amount:	$642,000
Maturity:	Nov. 3, 2022
Coupon:	7%, payable monthly
Price:	Par
Call:	At par if fund closes at or above initial level on any semiannual call date
Payout at maturity:	Par unless fund finishes below barrier level, in which case investors lose 1% for each 1% decline from initial level
Initial level:	$124.01
Barrier level:	$93.01; 75% of initial level
Pricing date:	Oct. 26, 2021
Settlement date:	Oct. 29, 2021
Agent:	Barclays
Fees:	1%
Cusip:	06748WMC4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.